Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT02983708

Neuroregenerative Potential of Intravenous G-CSF and Autologous Peripheral Blood Stem Cells

Neuroregenerative Potential of Intravenous G-CSF and Autologous Peripheral Blood Stem Cells in Children With Cerebral Palsy: a Randomized, Double-blind Cross-over Study

Sponsor: Hanyang University Seoul Hospital

Conditions Cerebral Palsy G-CSF Neurodegeneration Peripheral Blood Mononuclear Cells

Interventions G-CSF Peripheral blood mononuclear cells (mPBMC) Placebo

Updated 5 times since 2017 Last updated: Dec 5, 2016 Started: Aug 31, 2011 Primary completion: Sep 30, 2014 Completion: Sep 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Cerebral Palsy and G-CSF, this trial is completed. The trial is conducted by Hanyang University Seoul Hospital and has accumulated 5 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Aug 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hanyang University Seoul Hospital
Ministry of Health & Welfare, Korea

Data source: Hanyang University Seoul Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.